✦ LIBER ✦

Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial

✍ Scribed by Reni, Michele; Balzano, Gianpaolo; Aprile, Giuseppe; Cereda, Stefano; Passoni, Paolo; Zerbi, Alessandro; Tronconi, Maria Chiara; Milandri, Carlo; Saletti, Piercarlo; Rognone, Alessia; Fugazza, Clara; Magli, Alessandro; Muzio, Nadia Di; Carlo, Valerio Di; Villa, Eugenio

Book ID: 115031707
Publisher: Springer
Year: 2012
Tongue: English
Weight: 315 KB
Volume: 19
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-011-2205-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6599 Adjuvant PEFG (cisplatin, epirubici

6599 Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine in pancreatic cancer: a randomized phase II trial

✍ Reni, M.; Cereda, S.; Aprile, G.; Tronconi, M.C.; Milandri, C.; Passoni, P.; Rog 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

792 PUBLICATION Preliminary results of a

792 PUBLICATION Preliminary results of a phase II trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Neoadjuvant induction chemotherapy follo

Neoadjuvant induction chemotherapy followed by chemoradiation: a phase I trial of gemcitabine, cisplatin, and 5-fluorouracil for advanced pancreatic/gastrointestinal malignancies

✍ Staley, Charles A.; Harris, Wayne B.; Landry, Jerome; Small, William; Kooby, Dav 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 213 KB

6512 A randomized phase II trial of two

6512 A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel

✍ Cereda, S.; Reni, M.; Rognone, A.; Ghidini, M.; Rezzonico, S.; Passoni, P.; Mazz 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

A randomized phase II trial of two diffe

A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen)

✍ Michele Reni; Stefano Cereda; Alessia Rognone; Carmen Belli; Michele Ghidini; Si 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 274 KB

Docetaxel/gemcitabine or cisplatin/gemci

Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial

✍ D. Binder; H. Schweisfurth; C. Grah; C. Schäper; B. Temmesfeld-Wollbrück; G. Sie 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 340 KB